Peer review reports
From: BCG+MMC trial: adding mitomycin C to BCG as adjuvant intravesical therapy for high-risk, non-muscle-invasive bladder cancer: a randomised phase III trial (ANZUP 1301)
Original Submission |
28 Feb 2015 |
Submitted |
Original manuscript
|
|
Author responded |
Author comments
|
Resubmission - Version 2 |
|
Submitted |
Manuscript version 2
|
|
Author responded |
Author comments
|
Resubmission - Version 3 |
|
Submitted |
Manuscript version 3
|
Publishing |
13 May 2015 |
Editorially accepted |
|
27 May 2015 |
Article published |
10.1186/s12885-015-1431-6
|
Learn about peer review